StatBite: BRCA mutations in breast cancer patients under age 50 tested for mutations.

doi:10.1093/jnci/djq420

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

StatBite: BRCA mutations in breast cancer patients under age 50 tested for mutations.

Journal of the National Cancer Institute - 20 Oct 2010

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Breast Neoplasms
Share to Genes, BRCA1
Share to Genes, BRCA2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Jews

Share to Ovarian Neoplasms

Share to Pedigree

Share to Prevalence

Source

Open in PubMed

Identifiers

PMID: 20935267
DOI: 10.1093/jnci/djq420

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

StatBite: BRCA mutations in breast cancer patients under age 50 tested for mutations.PMID 20935267Read ↗

StatBite: BRCA Mutations Increase Risk of Breast/Ovarian Cancer.Semantic proximity Read ↗

BRCA in breast cancer: ESMO clinical recommendations.Semantic proximity Read ↗

BRCA screening.Semantic proximity Read ↗

JAMA patient page. BRCA genes and breast cancer.Semantic proximity Read ↗

Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening.Semantic proximity Read ↗

BRCA1 and BRCA2: to test or not to test.Semantic proximity Read ↗

Pros and cons of screening for BRCA mutations.Semantic proximity Read ↗

BRCA2: a 25-year journey from gene identification to targeted cancer treatment.Semantic proximity Read ↗

Experts say more women should be tested for BRCA1 and BRCA2 genetic mutations.Semantic proximity Read ↗

BRCA1, BRCA2, BRCA3 ... a myriad of breast cancer genes.Semantic proximity Read ↗

Biomedicine. D-Day for BRCA2.Semantic proximity Read ↗

Breast cancer in young women: do BRCA1 or BRCA2 mutations matter?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.